Table 1 Baseline characteristics.
From: Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
Variable | All patients | Female | Male | P-value |
|---|---|---|---|---|
(n = 203, 36.5%) | (n = 353, 63.5%) | |||
Age (years) | 56.8 (11.1) | 56.3 (11.4) | 57.1 (11.0) | 0.448 |
Etiology of liver cirrhosis | ||||
Alcohol-related | 52% (n = 291) | 44% (n = 89) | 57% (n = 202) | 0.002 |
Cryptogenic | 11% (n = 61) | 13% (n = 27) | 10% (n = 34) | 0.183 |
Viral | 18% (n = 102) | 17.2% (n = 35) | 19% (n = 67) | 0.61 |
NASH | 7% (n = 38) | 7% (n = 15) | 7% (n = 23) | 0.694 |
Cholestatic | 8% (n = 42) | 11% (n = 23) | 5% (n = 19) | 0.011 |
Other | 14% (n = 79) | 16% (n = 33) | 13% (n = 46) | 0.294 |
Mixed | 10% (n = 55) | 9% (n = 19) | 10% (n = 36) | 0.75 |
Cause of hospitalization | ||||
Ascites | 65% (n = 361) | 65% (n = 131) | 65% (n = 230) | 0.882 |
TIPS-Evaluation | 20% (n = 110) | 16% (n = 33) | 22% (n = 77) | 0.113 |
LTx-Evaluation | 14%(n = 78) | 14% (n = 29) | 14% (n = 49) | 0.895 |
HE | 6% (n = 32) | 5% (n = 10) | 6% (n = 22) | 0.524 |
HRS | 3% (n = 17) | 1% (n = 3) | 4% (n = 14) | 0.101 |
Worsening of general condition | 5% (n = 26) | 4% (n = 9) | 5% (n = 17) | 0.837 |
Infection | 2% (n = 10) | 2% (n = 4) | 2% (n = 6) | 0.817 |
ACLF | 2% (n = 10) | 2% (n = 4) | 2% (n = 6) | 0.817 |
Other cause | 29%(n = 161) | 34% (n = 69) | 26% (n = 92) | 0.047 |
PPI intake | 81% (n = 445) | 77% (n = 154) | 83% (n = 291) | 0.078 |
Β-blockers | 38% (n = 212) | 34% (n = 69) | 41% (n = 143) | 0.136 |
Esophageal varices | 76% (n = 422) | 69% (n = 140) | 80% (n = 282) | 0.003 |
Diabetes | 24% (n = 135) | 23% (n = 47) | 25% (n = 88) | 0.638 |
MELD score | 18 (7.0) | 17 (6.6) | 19 (7.2) | 0.016 |
Albumin (g/l) | 27.1 (5.9) | 26.6 (5.4) | 27.4 (6.2) | 0.273 |
Bilirubin (µmol/l) | 91.9 (135.4) | 86.6 (130.6) | 94.9 (138.2) | 0.488 |
CRP (mg/l) | 30.4 (34.7) | 30.1 (38.3) | 30.5 (32.5) | 0.903 |
INR (Ratio) | 1.53 (0.46) | 1.49 (0.37) | 1.55 (0.50) | 0.209 |
Creatinine (µmol/l) | 130.6 (89.2) | 115.6 (70.5) | 139.2 (97.3) | 0.003 |
Leukocytes (103/µl) | 8.8 (6.1) | 9.3 (5.9) | 8.6 (6.2) | 0.164 |
Platelets (103/µl) | 147.6 (102.7) | 160 (119.7) | 140 (90.8) | 0.029 |
Sodium (mmol/l) | 134 (5.4) | 134 (5.5) | 134 (5.3) | 0.863 |
Antibiotic intake within 12 weeks before admission | 33% (n = 180) | 32% (n = 64) | 33% (n = 116) | 0.818 |
